Monoclonal antibody specific for the cellular receptor of echoviruses

A D Mbida1, O G Gaudin, O Sabido

  • 1Department of Virology, Faculty of Medicine, CHU, St-Etienne, France.

Intervirology
|January 1, 1992
PubMed

Insights

A new monoclonal antibody (Mab 143) protects primate cell lines from echovirus (EV) infection by targeting a unique cell receptor. This antibody offers broad protection against most EV serotypes and coxsackievirus A9.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Primate cell lines possess specific membrane receptors for echoviruses (EV).
  • Understanding these receptors is crucial for developing antiviral strategies against picornaviruses.

Purpose of the Study:

  • To isolate and characterize a monoclonal antibody (Mab 143) that targets EV receptors on primate cells.
  • To evaluate the protective efficacy of Mab 143 against EV infection and identify the targeted receptor characteristics.

Main Methods:

  • Isolation and characterization of Mab 143 using KB cells.
  • Testing Mab 143's ability to protect various primate cell lines against EV-11 cytopathic effect (CPE).
  • Assessing Mab 143's reactivity with cell lines from different species and its effect on other picornaviruses.

Main Results:

  • Mab 143 was isolated and shown to react with KB cell membranes.
  • Mab 143 provided significant protection against EV-11 CPE in primate cell lines.
  • Protection extended to most EV serotypes and coxsackievirus A9, but not other picornaviruses.
  • Mab 143 specifically bound to human and simian cell lines, not bovine, canine, or rabbit.

Conclusions:

  • A unique receptor, targeted by Mab 143, is likely utilized by most echovirus serotypes for cell entry.
  • Mab 143 represents a potential therapeutic agent for echovirus infections.
  • This study elucidates the specific cell-virus interactions involved in echovirus pathogenesis.